Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE11.7100
- TODAY'S CHANGE (%)0.5400 (4.8344%)
- Bid / Lots11.3200/ 1
- Ask / Lots12.1700/ 1
- Open / Previous Close11.0700 / 11.1700
- Day Range
- 52 Week Range
- Volume977,911
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 11130 | 11.09 |
| 09:33 ET | 803 | 11.15 |
| 09:35 ET | 6201 | 10.91 |
| 09:37 ET | 850 | 10.97 |
| 09:39 ET | 800 | 10.97 |
| 09:42 ET | 2100 | 11 |
| 09:44 ET | 1400 | 11.05 |
| 09:48 ET | 700 | 11.11 |
| 09:50 ET | 266 | 11.11 |
| 09:51 ET | 700 | 11.06 |
| 09:53 ET | 2147 | 10.9732 |
| 09:57 ET | 5162 | 10.94 |
| 10:02 ET | 2540 | 10.995 |
| 10:04 ET | 1650 | 11.0657 |
| 10:06 ET | 500 | 11.065 |
| 10:08 ET | 2146 | 11.04 |
| 10:09 ET | 559 | 11.04 |
| 10:11 ET | 2714 | 10.97 |
| 10:13 ET | 2388 | 10.99 |
| 10:15 ET | 500 | 11 |
| 10:18 ET | 1114 | 11.02 |
| 10:20 ET | 22601 | 11.185 |
| 10:22 ET | 2690 | 11.26 |
| 10:24 ET | 6595 | 11.39 |
| 10:26 ET | 5781 | 11.345 |
| 10:27 ET | 860 | 11.36 |
| 10:29 ET | 2400 | 11.36 |
| 10:31 ET | 679 | 11.36 |
| 10:33 ET | 535 | 11.34 |
| 10:36 ET | 1755 | 11.34 |
| 10:38 ET | 450 | 11.35 |
| 10:40 ET | 2400 | 11.365 |
| 10:42 ET | 6144 | 11.28 |
| 10:44 ET | 300 | 11.275 |
| 10:45 ET | 2994 | 11.3 |
| 10:47 ET | 800 | 11.29 |
| 10:49 ET | 400 | 11.3 |
| 10:51 ET | 2750 | 11.29 |
| 10:54 ET | 33362 | 11.24 |
| 10:56 ET | 3259 | 11.26 |
| 10:58 ET | 1363 | 11.26 |
| 11:00 ET | 2134 | 11.22 |
| 11:02 ET | 588 | 11.185 |
| 11:03 ET | 2005 | 11.17 |
| 11:05 ET | 250 | 11.18 |
| 11:07 ET | 500 | 11.175 |
| 11:09 ET | 6411 | 11.2643 |
| 11:12 ET | 55372 | 11.24 |
| 11:14 ET | 3227 | 11.26 |
| 11:16 ET | 3798 | 11.26 |
| 11:18 ET | 2100 | 11.22 |
| 11:20 ET | 1366 | 11.22 |
| 11:21 ET | 3557 | 11.27 |
| 11:23 ET | 550 | 11.27 |
| 11:25 ET | 2760 | 11.3 |
| 11:27 ET | 6183 | 11.36 |
| 11:30 ET | 2490 | 11.39 |
| 11:32 ET | 1862 | 11.41 |
| 11:34 ET | 5163 | 11.47 |
| 11:36 ET | 4592 | 11.44 |
| 11:38 ET | 700 | 11.44 |
| 11:39 ET | 1200 | 11.43 |
| 11:41 ET | 3395 | 11.425 |
| 11:43 ET | 2378 | 11.43 |
| 11:45 ET | 4385 | 11.345 |
| 11:48 ET | 100 | 11.345 |
| 11:50 ET | 7210 | 11.375 |
| 11:52 ET | 5298 | 11.44 |
| 11:54 ET | 2398 | 11.45 |
| 11:56 ET | 3453 | 11.45 |
| 11:57 ET | 3845 | 11.49 |
| 11:59 ET | 100 | 11.49 |
| 12:01 ET | 1205 | 11.49 |
| 12:03 ET | 2362 | 11.5 |
| 12:06 ET | 300 | 11.52 |
| 12:08 ET | 2017 | 11.52 |
| 12:10 ET | 2259 | 11.53 |
| 12:12 ET | 7042 | 11.58 |
| 12:15 ET | 645 | 11.63 |
| 12:17 ET | 1448 | 11.615 |
| 12:19 ET | 3101 | 11.61 |
| 12:21 ET | 2600 | 11.625 |
| 12:24 ET | 1700 | 11.64 |
| 12:26 ET | 1048 | 11.66 |
| 12:28 ET | 900 | 11.67 |
| 12:30 ET | 1868 | 11.69 |
| 12:32 ET | 2083 | 11.68 |
| 12:33 ET | 1200 | 11.67 |
| 12:35 ET | 3432 | 11.755 |
| 12:37 ET | 6836 | 11.82 |
| 12:39 ET | 3875 | 11.87 |
| 12:42 ET | 853 | 11.9 |
| 12:44 ET | 8061 | 11.89 |
| 12:46 ET | 1000 | 11.89 |
| 12:48 ET | 3298 | 11.825 |
| 12:50 ET | 800 | 11.82 |
| 12:51 ET | 750 | 11.82 |
| 12:53 ET | 4593 | 11.785 |
| 12:55 ET | 2825 | 11.79 |
| 12:57 ET | 2718 | 11.7624 |
| 01:00 ET | 1350 | 11.77 |
| 01:02 ET | 4018 | 11.74 |
| 01:04 ET | 5476 | 11.72 |
| 01:06 ET | 600 | 11.7 |
| 01:08 ET | 8010 | 11.79 |
| 01:09 ET | 800 | 11.81 |
| 01:11 ET | 100 | 11.82 |
| 01:13 ET | 1228 | 11.86 |
| 01:15 ET | 6581 | 11.9 |
| 01:18 ET | 3911 | 11.93 |
| 01:20 ET | 548 | 11.94 |
| 01:22 ET | 3517 | 11.845 |
| 01:26 ET | 4062 | 11.81 |
| 01:27 ET | 300 | 11.795 |
| 01:29 ET | 3930 | 11.79 |
| 01:31 ET | 727 | 11.8 |
| 01:33 ET | 400 | 11.8 |
| 01:36 ET | 1600 | 11.815 |
| 01:40 ET | 200 | 11.815 |
| 01:42 ET | 300 | 11.82 |
| 01:44 ET | 2458 | 11.8541 |
| 01:45 ET | 1087 | 11.845 |
| 01:47 ET | 1222 | 11.845 |
| 01:49 ET | 1951 | 11.84 |
| 01:51 ET | 100 | 11.84 |
| 01:54 ET | 821 | 11.825 |
| 01:56 ET | 700 | 11.82 |
| 01:58 ET | 1300 | 11.81 |
| 02:00 ET | 3474 | 11.795 |
| 02:02 ET | 200 | 11.795 |
| 02:03 ET | 900 | 11.805 |
| 02:05 ET | 1252 | 11.835 |
| 02:07 ET | 1552 | 11.81 |
| 02:09 ET | 900 | 11.78 |
| 02:12 ET | 900 | 11.77 |
| 02:14 ET | 200 | 11.77 |
| 02:16 ET | 245 | 11.77 |
| 02:18 ET | 7055 | 11.715 |
| 02:20 ET | 17815 | 11.71 |
| 02:21 ET | 2880 | 11.72 |
| 02:23 ET | 600 | 11.73 |
| 02:25 ET | 248 | 11.73 |
| 02:27 ET | 3015 | 11.69 |
| 02:30 ET | 650 | 11.69 |
| 02:32 ET | 1000 | 11.69 |
| 02:34 ET | 3852 | 11.72 |
| 02:36 ET | 800 | 11.72 |
| 02:38 ET | 900 | 11.715 |
| 02:39 ET | 2226 | 11.765 |
| 02:41 ET | 2139 | 11.75 |
| 02:43 ET | 1100 | 11.74 |
| 02:45 ET | 400 | 11.74 |
| 02:48 ET | 848 | 11.74 |
| 02:50 ET | 486 | 11.735 |
| 02:52 ET | 1000 | 11.73 |
| 02:54 ET | 9814 | 11.715 |
| 02:56 ET | 9385 | 11.74 |
| 02:57 ET | 6921 | 11.76 |
| 02:59 ET | 3080 | 11.75 |
| 03:01 ET | 6457 | 11.75 |
| 03:03 ET | 3105 | 11.77 |
| 03:06 ET | 300 | 11.77 |
| 03:08 ET | 1878 | 11.765 |
| 03:10 ET | 1200 | 11.765 |
| 03:12 ET | 4388 | 11.73 |
| 03:14 ET | 253 | 11.73 |
| 03:15 ET | 4366 | 11.68 |
| 03:17 ET | 800 | 11.66 |
| 03:21 ET | 922 | 11.66 |
| 03:24 ET | 300 | 11.67 |
| 03:26 ET | 5472 | 11.685 |
| 03:28 ET | 1749 | 11.72 |
| 03:30 ET | 11990 | 11.75 |
| 03:32 ET | 2784 | 11.73 |
| 03:33 ET | 2347 | 11.7 |
| 03:35 ET | 1250 | 11.69 |
| 03:37 ET | 400 | 11.68 |
| 03:39 ET | 4382 | 11.68 |
| 03:42 ET | 6063 | 11.72 |
| 03:44 ET | 7340 | 11.75 |
| 03:46 ET | 1801 | 11.71 |
| 03:48 ET | 6352 | 11.725 |
| 03:50 ET | 1889 | 11.73 |
| 03:51 ET | 10756 | 11.71 |
| 03:53 ET | 26870 | 11.71 |
| 03:55 ET | 18674 | 11.71 |
| 03:57 ET | 24916 | 11.715 |
| 04:00 ET | 124179 | 11.71 |
Oct 29, 2024
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024, from 7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 18, 2024
DJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 6:16AM ET on Friday Oct 18, 2024 by Dow Jones
6:16AM ET on Friday Oct 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 1.8B | -7.0x | --- |
Spyre Therapeutics Inc | 1.7B | -2.3x | --- |
Viridian Therapeutics Inc | 1.7B | -5.4x | --- |
Tarsus Pharmaceuticals Inc | 1.8B | -10.4x | --- |
Celldex Therapeutics Inc | 1.7B | -9.3x | --- |
Syndax Pharmaceuticals Inc | 1.6B | -5.6x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.66 |
Book Value | $2.95 |
P/E Ratio | -7.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
